Cost-effectiveness analysis of increasing drug therapy coverage for patients with coronary artery disease in combination with atrial fibrillation and heart failure

Cost-effectiveness analysis of increasing drug therapy coverage for patients with coronary artery disease in combination with atrial fibrillation and heart failure

Aim. To make a cost-effectiveness analysis of increasing the prescription rate of combination therapy with beta-blockers (BBs), angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs), statins and oral anticoagulants (OACs) in patients with coronary artery disease (CAD...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. I. Ignatieva, A. V. Kontsevaya, M. M. Lukyanov, V. G. Klyashtorny, O. M. Drapkina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2024-05-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	combination of coronary artery disease heart failure and atrial fibrillation drug therapy coverage clinical and economic study
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3950
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of atrial fibrillation with coronary bed lesions (according to the coronary angiography register)
by: E. I. Yaroslavskaya, et al.
Published: (2019-08-01)

NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES
by: G. S. Galjautdinov1, et al.
Published: (2018-07-01)

A ROLE OF SUPEROXIDE DISMUTASE IN DEVELOPMENT OF POST-OPERATION ATRIAL FIBRILLATION IN CORONARY HEART DISEASE PATIENTS
by: O. A. Rubanenko, et al.
Published: (2017-03-01)

Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure
by: V. V. Kirillova, et al.
Published: (2020-11-01)

Lipid exchange and inflammatory markers in patients with coronary artery disease and atrial fibrillation
by: I. O. Melnychuk, et al.
Published: (2023-09-01)

A new method of left atrial appendage occlusion for the prevention of thromboembolic complications in patients with atrial fibrillation during coronary artery bypass grafting
by: Yu. Yu. Vecherskiy, et al.
Published: (2020-09-01)

Pathophysiology, Diagnosis, and Management of Coronary Artery Disease in the Setting of Atrial Fibrillation
by: Georgiana Pintea Bentea, et al.
Published: (2024-12-01)

Pathogenic Mechanisms of Atrial Fibrillation in Obesity
by: O. M. Drapkina, et al.
Published: (2016-11-01)

Inflammatory continuum in the pathogenesis of atrial fibrillation after coronary bypass surgery
by: A. R. Mingalimova, et al.
Published: (2022-03-01)

Echo-cardiographic parameters for atrial fibrillation in combination with acute coronary syndrome in real clinical practice according to register of acute coronary syndrome in the Krasnodar region
by: Z. G. Tatarintseva, et al.
Published: (2019-04-01)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Correlation between severe coronary stenosis and recurrence after atrial fibrillation cryoablation
by: LUO Xiaoying, DONG Fengwei, XU Yan, WU Liqun, QI Wenhang
Published: (2025-06-01)

Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness”
by: S. V. Malchikova, et al.
Published: (2019-10-01)

Platelets characteristics in patients with coronary artery disease and atrial fibrillation
by: I. O. Melnychuk
Published: (2023-12-01)

MANAGEMENT AND OUTCOMES IN ACUTE CORONARY SYNDROME WITH ATRIAL FIBRILLATION IN “NON-INVASIVE” CLINIC
by: A. D. Erlikh, et al.
Published: (2017-02-01)

CLINICAL IMPRESSION: PLANNED PERCUTANEOUS CORONARY INTERVENTION IN A PATIENT WITH ATRIAL FIBRILLATION
by: Andrei I. Komarov
Published: (2018-12-01)

PRESCRIPTION OF MEDICATIONS INFLUENCING PROGNOSIS IN ATRIAL FIBRILLATION WITH ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, CHRONIC HEART FAILURE, BY THE REGISTRY REKVAZA-CLINIC
by: E. V. Stepina, et al.
Published: (2017-04-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation
by: V. A. Brazhnik, et al.
Published: (2021-03-01)

STRATEGY TO MINIMIZE THE BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION WHO RECEIVE COMBINED ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
by: D. A. Zateishchikov
Published: (2018-05-01)

Practical aspects of antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Zh. D. Kobalava, et al.
Published: (2021-10-01)

Perfect storm: a clinical case of multisite (brain, coronary, renal and spleen) embolism in patient with atrial fibrillation
by: N. I. Novitsky, et al.
Published: (2023-09-01)

Predicting Methods for Analyzing Data on Fatal Outcome Possibility in the Combination of Acute Coronary Syndrome and Atrial Fibrillation According to the Krasnodar Region Registry
by: Z. G. Tatarintseva, et al.
Published: (2019-07-01)

Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl)
by: V. V. Yakusevich, et al.
Published: (2023-11-01)

Prognostic impact of early and late newly diagnosed atrial fibrillation in acute myocardial infarction treated with percutaneous coronary intervention
by: Xi Wu, et al.
Published: (2025-07-01)

ATRIAL FIBRILLATION: FUNCTIONAL CLASSIFICATION
by: A. V. Germanov, et al.
Published: (2020-11-01)

Influence of blood electrolyte levels on the risk of atrial fibrillation after cardiac surgery
by: Z. G. Tatarintseva, et al.
Published: (2024-04-01)

Clinical, echocardiographic parameters and markers of oxidative stress associated with atrial fibrillation in patients undergoing coronary artery bypass graft surgery
by: O. A. Rubanenko, et al.
Published: (2020-08-01)

Atrio-ventricular kinetics in patients with coronary heart disease and atrial fibrillation
by: N. S. Volkova, et al.
Published: (2008-06-01)

ATRIAL FIBRILLATION IN CARDIOVASCULAR INTERVENTIONS IN ON-PUMP AND OFF-PUMP REGIMENS
by: O. A. Rubanenko, et al.
Published: (2015-11-01)

Heart rate variability and trans-esophageal atrial stimulation data in predicting recurrent atrial fibrillation paroxysms
by: T. V. Setyn, et al.
Published: (2007-12-01)

Prediction of atrial fibrillation in patients with coronary artery disease using mathematical modeling methods
by: S. V. Kuzin, et al.
Published: (2025-07-01)

Real-world antithrombotic strategies in patients with atrial fibrillation and recently developed acute coronary syndrome
by: Hiroshi Iwata, et al.
Published: (2025-03-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

The role of inflammatory markers in atrial fibrillation: a review
by: S. V. Grigoryan, et al.
Published: (2012-10-01)

Features of Structural and Functional Changes in the Heart in Elderly Patients with Coronary Heart Disease and Atrial Fibrillation
by: L. I. Folomeeva, et al.
Published: (2020-09-01)

EFFICACY OF CORONARY BYPASS AND RADIOFREQUENCY ABLATION IN ATRIAL FIBRILLATION PATIENTS WITH CHRONIC KIDNEY DISEASE
by: B. G. Iskenderov, et al.
Published: (2015-12-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016-01-01)

The prevalence of sleep breathing disorders in patients with atrial fibrillation undergoing catheter treatment
by: M. V. Agaltsov, et al.
Published: (2019-03-01)